HomeBLRX • NASDAQ
add
BioLine RX Ltd - ADR
Previous close
$5.27
Day range
$5.14 - $5.55
Year range
$2.30 - $35.60
Market cap
18.66M USD
Avg Volume
1.29M
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 255.00K | -96.28% |
Operating expense | 2.61M | -74.45% |
Net income | 5.13M | 836.64% |
Net profit margin | 2.01K | 19,908.77% |
Earnings per share | 0.00 | — |
EBITDA | -2.23M | 43.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.37M | -6.40% |
Total assets | 43.51M | -15.68% |
Total liabilities | 22.65M | -41.24% |
Total equity | 20.86M | — |
Shares outstanding | 2.23B | — |
Price to book | 527.00 | — |
Return on assets | -14.51% | — |
Return on capital | -18.94% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 5.13M | 836.64% |
Cash from operations | -2.59M | 81.64% |
Cash from investing | -8.18M | -149.00% |
Cash from financing | 9.45M | 1,157.05% |
Net change in cash | -1.40M | -180.69% |
Free cash flow | -200.88K | 99.19% |
About
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
Founded
2003
Website
Employees
28
